Trials / Completed
CompletedNCT01935739
Discordant HER2/Neu Status of Breast Cancer.
Discordant HER2/Neu Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- National Cancer Institute, Thailand · Other Government
- Sex
- Female
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine discordant HER2/neu status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.
Detailed description
HER2/neu status of primary breast tumor and axillary lymph nodes were tested by IHC staining. In the cases of equivocal result of IHC, FISH test were performed. The result of HER2/neu status between primary breast tumor and axillary lymph node were analyzed.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2013-09-05
- Last updated
- 2013-09-17
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01935739. Inclusion in this directory is not an endorsement.